The findings of the present study are consistent with the above-mentioned assumptions—GDM G2, thus insulin-treated mothers, had the lowest gestational weight gain but the highest values of fasting glucose in the first and second/third trimesters, 1 h post-OGTT glucose, as well as HbA1c and HOMA-IR. This evidence concerns the gene INS and gestational diabetes.